Clover cancels AIM listing
Thursday, 19 January, 2006
Sydney-based Clover (ASX:CLV) has applied to the London Stock Exchange to cancel its listing on the Alternative Investment Market (AIM).
The cancellation is expected to take effect from February 16.
Clover's board felt that the costs associated with maintaining a dual listing on AIM and the ASX outweighed any benefits gained and the company will not be looking to raise new capital on AIM in the foreseeable future. All shareholdings registered in the UK on AIM will be automatically transferred following the delisting and will remain tradable as ordinary shares on the ASX.
Scientists uncover how cancer cells hide from immune system
By targeting the RNA helicase known as DDX6, scientists could enable the immune system to...
Vanillin flavouring in vapes may disrupt embryo development
Vanillin — a common flavouring chemical in e-cigarettes — may disrupt the normal...
Heart valve tissues created from stem cells
The breakthrough should help advance our understanding into how human heart valves develop,...
